Airsculpt Technologies, Inc. AIRS

Despite a 2.5% revenue dip, the company posts its second consecutive quarter of case growth and expands its procedure portfolio to capture the GLP-1 market.

AirSculpt Technologies reported past second-quarter 2026 results showing sales of US$42.9 million versus US$44.01 million a year earlier and a wider net loss of US$1.11 million, while six-month sales slipped to US$82.29 million with a modestly higher cumulative net loss of US$3.51 million. Despite the softer top line and continued losses, the company reaffirmed its full-year 2026 revenue outlook at the lower end of its US$151 million to US$157 million guidance range, signaling management’s...